AddexBio H460 cells (大細胞肺癌) H460 cells(C0016003)-細胞株/菌種-試劑-生物在線
蘇州達麥迪生物醫學科技有限公司
AddexBio H460 cells (大細胞肺癌) H460 cells(C0016003)

AddexBio H460 cells (大細胞肺癌) H460 cells(C0016003)

商家詢價

產品名稱: AddexBio H460 cells (大細胞肺癌) H460 cells(C0016003)

英文名稱: H460 cells

產品編號: C0016003

產品價格: 0

產品產地: 美國

品牌商標: AddexBio

更新時間: null

使用范圍: null

蘇州達麥迪生物醫學科技有限公司
  • 聯系人 :
  • 地址 : 蘇州高新區錦峰路8號1號樓501-503室
  • 郵編 :
  • 所在區域 : 上海
  • 電話 : 173****6276 點擊查看
  • 傳真 : 點擊查看
  • 郵箱 : info@moreybio.com

Disease:

Large cell lung carcinoma 

Origin:

Derived from metastatic pleural effusion 

Species:

Homo sapiens 

Tissue:

Lung 

Morphology:

Epithelial 

Properties:

Adherent 

Cytogenic data:

This is a hypotriploid human cell line 

Patient:

Medium:

RPMI1640 + 10% FBS 

Subculture:

1:3 to 1:8 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37°C 

Freezing Medium:

Complete culture medium supplemented with 5% (v/v) DMSO 

Biosafety Level:
 I 
Sterility:

Bacteria: Negative 

Yeast: Negative 

Mycoplasma: Negative 

Pathogens:

HIV: Negative 

Hepatitis B: Negative 

Hepatitis C: Negative 

Isoenzymes:
 AK-1, 1; ES-D, 1; G6PD, B; GLO-I, 1-2; Me-2, 1; PGM1, 1; PGM3, 1 
DNA Profile (STR):
 Amelogenin: X,Y; CSF1PO: 11,12; D13S317: 13; D16S539: 9; D5S818: 9,10; D7S820: 9,12; THO1: 9.3; TPOX: 8; vWA: 17 
Mutations in H460 Cells 

Related cells by Organ:

A427 cells 

A549 cells 

Calu3 cells 

H460 cells 


References for H460 cells:

1. Lim, S. J., Choi, M. K., Kim, M. J., and Kim, J. K. Alpha-tocopheryl succinate potentiates the paclitaxel-induced apoptosis through enforced caspase 8 activation in human H460 lung cancer cells. Exp Mol Med, 41: 737-745, 2009. 

2. Pesic, M., Podolski, A., Rakic, L., and Ruzdijic, S. Purine analogs sensitize the multidrug resistant cell line (NCI-H460/R) to doxorubicin and stimulate the cell growth inhibitory effect of verapamil. Invest New Drugs, 28: 482-492. 

3. Liu, H., Li, L., Li, X. Q., Liu, X. J., and Zhen, Y. S. Enediyne lidamycin enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib, in epidermoid carcinoma A431 cells and lung carcinoma H460 cells. Anticancer Drugs, 20: 41-49, 2009. 

4. Mollah, M. L., Song, J. C., Park, C. H., Lee, G. D., Hong, J. H., Ryoo, Z. Y., Lee, S., Chang, K. T., and Kim, K. S. Anticancer activity and apoptotic effects of Bulnesia sarmienti against human lung cancer H460 cells. Oncol Res, 18: 259-267, 2009. 

5. Borgovan, T., Bellistri, J. P., Slack, K. N., Kopelovich, L., Desai, M., and Joe, A. K. Inhibition of BCL2 expression and activity increases H460 sensitivity to the growth inhibitory effects of polyphenon E. J Exp Ther Oncol, 8: 129-144, 2009. 

6. Pesic, M., Andjelkovic, T., Bankovic, J., Markovic, I. D., Rakic, L., and Ruzdijic, S. Sulfinosine enhances doxorubicin efficacy through synergism and by reversing multidrug resistance in the human non-small cell lung carcinoma cell line (NCI-H460/R). Invest New Drugs, 27: 99-110, 2009.